Mkt Cap$2.28T-2.68%
24h Vol$87.00B
BTC Dom56.1%
ETH Dom9.2%
F&G15Extreme Fear
BTC$63,791.00-3.28% ETH$1,729.55-3.77% USDT$0.9989-0.01% BNB$590.87-2.85% USDC$0.99970.00% XRP$1.17-4.14% SOL$70.92-4.02% TRX$0.3201+0.93% FIGR_HELOC$1.02-1.42% HYPE$69.09-7.48% DOGE$0.0844-3.67% USDS$0.99960.00% RAIN$0.0145+2.88% LEO$9.71+1.47% ZEC$468.51-8.24% XLM$0.2313+2.43% BTC$63,791.00-3.28% ETH$1,729.55-3.77% USDT$0.9989-0.01% BNB$590.87-2.85% USDC$0.99970.00% XRP$1.17-4.14% SOL$70.92-4.02% TRX$0.3201+0.93% FIGR_HELOC$1.02-1.42% HYPE$69.09-7.48% DOGE$0.0844-3.67% USDS$0.99960.00% RAIN$0.0145+2.88% LEO$9.71+1.47% ZEC$468.51-8.24% XLM$0.2313+2.43%
M-8.59% Earnings

Neogen Corporation (NEOG) Q3 Results: $0.12 EPS, $228.8M in Revenue

Neogen Corporation (NASDAQ: NEOG) has reported a revenue of $228.8 million for the third quarter of fiscal year 2024.

Neogen Corporation (NEOG) Q3 Mixed Results: $0.12 EPS, $228.8M in Revenue
Image courtesy of 123rf.com
Editorial disclosureRead more

All reviews, research, news and assessments of any kind on The Tokenist are compiled using a strict editorial review process by our editorial team. Neither our writers nor our editors receive direct compensation of any kind to publish information on tokenist.com. Our company, Tokenist Media LLC, is community supported and may receive a small commission when you purchase products or services through links on our website. Click here for a full list of our partners and an in-depth explanation on how we get paid.

Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our website policy prior to making financial decisions.

Neogen Corporation (NASDAQ: NEOG) has recently disclosed its financial outcomes for the third quarter of the fiscal year 2024, marking significant milestones despite facing operational challenges.

The company reported a revenue of $228.8 million, reflecting a 4.8% increase from the previous year’s $218.3 million. This growth is attributed to the successful integration of the former 3M Food Safety business, including the relocation of the pathogen detection and sample handling product lines.

Neogen’s CEO, John Adent, highlighted the completion of significant integration milestones and the ongoing efforts to address operational inefficiencies that have temporarily impacted order fulfillment rates.

Despite these challenges, Neogen’s adjusted net income remained stable at $26.4 million, equivalent to $0.12 per diluted share, closely mirroring the prior year’s performance.

The company also saw an improvement in its gross margin, which rose to 51.1% from 49.5% a year ago, mainly due to increased sales of higher-margin products in the Food Safety segment. However, a net loss of $2.0 million, or $0.01 per diluted share, was reported, contrasting with a net income of $8.2 million, or $0.04 per diluted share, in the same quarter of the previous year. This loss is primarily attributed to higher depreciation expenses and the ongoing operational inefficiencies from the integration process.

Neogen Corporation Reports $230.01 M in Revenue for Q3, Falls Short of Expectations by $1.21 Million

Comparing Neogen’s performance against market expectations reveals a mixed picture. Analysts had projected earnings per share (EPS) of $0.015 and revenue of $230.01 million for the quarter.

While the company slightly missed the revenue target of $228.8 million, it surpassed the EPS expectations, reporting $0.12 per diluted share on an adjusted basis.

This discrepancy underscores the impact of the operational challenges Neogen faces, which have tempered its ability to fully capitalize on the improving end-market demand. Despite these hurdles, the company’s core revenue growth and the strategic expansion of its scale through the merger with the 3M Food Safety Division indicate a strong underlying business performance.

Neogen Corp. Expects Full-Year Revenue Between $910 to $920 Million

Neogen has updated its full-year outlook to reflect the slower-than-anticipated recovery of order fulfillment rates, which are crucial for meeting consistent end-market demand.

The company now expects revenue to be between $910 million to $920 million, with adjusted EBITDA projected between $210 million and $215 million. This revised guidance considers the current operational inefficiencies and their impact on revenue generation.

Additionally, Neogen anticipates capital expenditures of approximately $130 million, with a significant portion allocated to integrating the former 3M Food Safety Division. This investment underscores the company’s commitment to overcoming the present challenges and capitalizing on the long-term benefits of its strategic initiatives.

Disclaimer: The author does not hold or have a position in any securities discussed in the article.


Tim Fries

Tim Fries

Author · Tokenist

Tim Fries is the cofounder of The Tokenist. He has a B. Sc. in Mechanical Engineering from the University of Michigan, and an MBA from the University of Chicago Booth School of Business. Tim served as a Senior Associate on the investment team at RW Baird's US Private Equity division, and is also the co-founder of Protective Technologies Capital, an investment firm specializing in sensing, protection and control solutions.

Related Stories